The observed effects on cognition and neuroplasticity are interesting to ischemic stroke research since pan-PDE4 inhibitors might exert similar effects in the chronic phase of stroke pathophysiology thereby contributing to improved functional recovery in the later phase of the disease course. The gene discussed is PDE4A; the disease is ischemic stroke.